Kamada CFO reports three stock option awards

Each option award vests in four equal installments, with 25% vesting on each anniversary of its grant date.

Rhea-AI Filing Summary

Orlev Chaime, KAMADA LTD (KMDA)'s Chief Financial Officer, reported three employee stock option awards on August 27, 2026, held by a trustee under the Company's 2011 Share Award Plan. The awards cover 22,500, 90,000 and 90,000 ordinary shares, with respective exercise prices adjusted to $5.98, $6.02 and $7.44 in connection with a special cash dividend. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Grant/Award: 202,500 shares

Grant/Award 3 txns

Insider ORLEV CHAIME

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1, F4, F2, F3	22,500	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F1, F5, F2, F3	90,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F1, F6, F2, F3	90,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 202,500 contracts (Indirect, Held by trustee)

Footnotes (6)

1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.
4. F4. This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. F5. This option was previously reported as covering 90,000 ordinary shares at an exercise price of $6.19. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
6. F6. This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Key Figures

Underlying ordinary shares, first option award: 22,500 shares Exercise price, first option award: $5.98 per share Underlying ordinary shares, second option award: 90,000 shares +4 more

7 metrics

Underlying ordinary shares, first option award 22,500 shares Award reported August 27, 2026

Exercise price, first option award $5.98 per share Award reported August 27, 2026; presented in U.S. dollars

Underlying ordinary shares, second option award 90,000 shares Award reported August 27, 2026

Exercise price, second option award $6.02 per share Award reported August 27, 2026; presented in U.S. dollars

Underlying ordinary shares, third option award 90,000 shares Award reported August 27, 2026

Exercise price, third option award $7.44 per share Award reported August 27, 2026; presented in U.S. dollars

Vesting installment 25% Each of four anniversaries of the grant date

Key Terms

Employee Stock Option (right to buy), exercise price, vest, 2011 Share Award Plan, +1 more

5 terms

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy)"

exercise price financial

"at an exercise price of $6.15"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"Options vest in four equal installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

2011 Share Award Plan financial

"under the Company's 2011 Share Award Plan"

special cash dividend financial

"special cash dividend distribution declared by the Company's board"

A special cash dividend is a one-time, extra cash payment a company gives to its shareholders in addition to its regular dividends, like a bonus check sent out when a business has more cash than usual. It matters to investors because it delivers immediate cash value, can signal that the company has strong short-term cash or limited opportunities to reinvest, and typically reduces the company’s cash reserves and may affect the stock price and tax treatment for recipients.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What option awards did KMDA's CFO report?

Orlev Chaime, KAMADA LTD's Chief Financial Officer, reported employee stock option awards covering 22,500, 90,000 and 90,000 ordinary shares on August 27, 2026. The awards were held by a trustee under the Company's 2011 Share Award Plan.

What are the KMDA option exercise prices and vesting terms?

The respective exercise prices were $5.98, $6.02 and $7.44. The prices are presented in U.S. dollars based on the Bank of Israel NIS/USD exchange rate published as of September 22, 2026. Each option vests in four equal installments, with 25% vesting on each of the four anniversaries of the grant date.

Why were the KMDA option exercise prices adjusted?

The exercise prices were adjusted in connection with a special cash dividend declared by the Company's board on August 17, 2026, with a record date of August 27, 2026. The respective prior prices were $6.15, $6.19 and $7.61.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 03:54 PM Accepted by SEC EDGAR 09/23/2026 - 03:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ORLEV CHAIME

(Last) (First) (Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$5.98(1)(4)	08/27/2026		A		22,500		(2)	(2)	Ordinary Shares	22,500	$0.00	22,500	I	Held by trustee(3)
Employee Stock Option (right to buy)	$6.02(1)(5)	08/27/2026		A		90,000		(2)	(2)	Ordinary Shares	90,000	$0.00	90,000	I	Held by trustee(3)
Employee Stock Option (right to buy)	$7.44(1)(6)	08/27/2026		A		90,000		(2)	(2)	Ordinary Shares	90,000	$0.00	90,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

3. Held by trustee under the Company's 2011 Share Award Plan.

4. This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

5. This option was previously reported as covering 90,000 ordinary shares at an exercise price of $6.19. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

6. This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

	/s/ Chaime Orlev	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)